About Balchem

For over 50 years, Balchem has developed innovative solutions for the health and nutritional needs of the world. With a diversified business portfolio, our products and technologies impact the health and wellbeing of millions of humans and animals worldwide. We provide the service, quality, and technology that enables our customers to win with their customers and have built a reputation for delivering results for all of our stakeholders.

Balchem consists of three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Human Nutrition & Health

Our Human Nutrition & Health business leverages decades of expertise in market insights, proven science, and product development to create winning solutions in health, wellbeing, and nutrition.

Dairy cows in a field

Animal Nutrition & Health

As a global leader of choline production and encapsulation technology, Balchem Animal Nutrition & Health provides a portfolio of nutrition products for ruminants, monogastrics, and companion animals.

Blue syringes lined up in packaging

Specialty Products

Performance Gases specializes in the packaging and global distribution of select gases. Plant Nutrition provides Metalosate® chelated minerals to the agricultural market worldwide.

Investor Relations

Balchem is a publicly-traded company listed on the NASDAQ under BCPC.  Explore our Investor Relations section to learn about our goals and strategies to support your investment decision and increase long-term shareholder value.

 

 

Balchem Latest News

In an ever-shifting and fast-growing industry, it’s important to stay informed. Explore our financial updates, innovative solutions, groundbreaking technologies, industry research and other important news from Balchem.

June 21, 2022

Balchem Corporation Completes Acquisition of Kappa Bioscience AS

We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
June 14, 2022

Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS

Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
April 29, 2022

Balchem Corporation Reports First Quarter 2022 Financial Results

Ted Harris, Chairman, CEO, and President of Balchem said, “We are very pleased to have continued the strong momentum from 2021 into 2022. In the first quarter of 2022 we delivered all-time record sales, adjusted net earnings, and adjusted EBITDA in a very difficult macro-economic and geo-political environment.”

Join Our Team

All great solutions start with a problem and someone who’s willing to solve it. At Balchem, we recognize the value of a good idea and strive to continuously grow our team of talented individuals from all corners of the globe who share a passion for science and a knack for problem-solving. Explore our Career section to learn more about what it means to be an employee at Balchem and view all current opportunities.